Lisdexamfetamine 30 MG capsule 90S
Ended Awarded
- Contract number
- SPE2DR26F13AH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,846
Award facts
- Contract value 100% obligated
- $2,846.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,846.19 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 30 mg capsules (90-count units) with a firm fixed price structure. The award was made on November 14, 2025, with an ultimate completion date of November 17, 2025, and represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, executed this delivery order as a child contract under its larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vehicle running through December 2026 that provides comprehensive global pharmaceutical support to military healthcare systems worldwide.
This delivery order exemplifies the operational execution of AmerisourceBergen's expansive pharmaceutical supply relationship with the federal government. The company maintains a robust portfolio of federal medical procurement contracts covering diverse therapeutic domains, from specialty medications to generic drugs and medical supplies, serving the Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The lisdexamfetamine procurement supports medical supply chain operations across military treatment facilities and veteran healthcare systems, demonstrating the company's critical role in sustaining pharmaceutical availability for the Department of Defense's medical infrastructure.
Quick answers
Who was awarded contract SPE2DR26F13AH?
SPE2DR26F13AH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F13AH worth?
The government has obligated $2,846 on SPE2DR26F13AH.
Is contract SPE2DR26F13AH an order under another contract?
Yes. SPE2DR26F13AH is a delivery order under SPE2DR25D1110, an indefinite delivery contract.
Was contract SPE2DR26F13AH competed?
The extent of competition for SPE2DR26F13AH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award